caa a22 4500 397519869 CHVBK 20180308164629.0 cr unu---uuuuu 161202e199503 xx s 000 0 eng 10.1093/heapol/10.1.40 doi (NATIONALLICENCE)oxford-10.1093/heapol/10.1.40 Essential drugs for ration kits in developing countries [Elektronische Daten] [HILBRAND HAAK, HANS V HOGERZEIL] Since the early 1980s drug ration kits have been used to improve the supply of essential drugs to rural health facilities in developing countries. This paper evaluates some of the experiences with kit systems in Angola, Bhutan, Democratic Yemen, Guinea-Conakry, Kenya, Mozambique, Sudan, Tanzania, Uganda and Zambia in relation to the selection of drugs for the kits and their quantities and cost. Data were collected through a review of published papers, annual reports and programme evaluations, by questionnaires among field staff and interviews with key experts. In comparing the 10 programmes, 21 drugs can be identified that are used in at least two-thirds of all kits. This list may be useful for evaluation and planning purposes. Six drugs (ORS, chloroquine and 4 antibiotics) usually account for over 60% of the cost of the kit. Careful monitoring of the price and quantities of these 6 drugs can therefore be very cost-effective. In the absence of reliable data on morbidity and drug needs in the initial phases of a kit system, the median drug quantities in kits from these 10 countries may serve as a starting point. Accumulating surpluses are sometimes perceived as a serious disadvantage of kit systems, ORS, benzyl-benzoate solution and iron tablets are the three drugs that have most frequently accumulated. These drugs are relatively cheap and usually have a long shelf-life; in most programmes they have been successfully redistributed to other health facilities while the kit content was being adapted. The overall financial loss due to accumulation of surpluses is therefore limited. Most programmes have reached a stable kit content within two years. © Oxford University Press Review article nationallicence HAAK HILBRAND aut HOGERZEIL HANS V. aut Health Policy and Planning Oxford University Press 10/1(1995-03), 40-49 0268-1080 10:1<40 1995 10 heapol https://doi.org/10.1093/heapol/10.1.40 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1093/heapol/10.1.40 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- HAAK HILBRAND aut NATIONALLICENCE 700 1- HOGERZEIL HANS V. aut NATIONALLICENCE 773 0- Health Policy and Planning Oxford University Press 10/1(1995-03), 40-49 0268-1080 10:1<40 1995 10 heapol Metadata rights reserved CC BY-NC-4.0 http://creativecommons.org/licenses/by-nc/4.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-oxford